Mezzion Pharma Co.Ltd Working Capital to Net Assets Ratio
Mezzion Pharma Co.Ltd working capital to net assets ratio. Mezzion Pharma Co.Ltd (140410) has a Working Capital to Net Assets ratio of -69.3% as of June 2026. Working capital of ₩-27.06 Billion (current assets of ₩58.07 Billion minus current liabilities of ₩85.13 Billion) is measured against net assets of ₩39.04 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Mezzion Pharma Co.Ltd (2012–2025)
Working capital to net assets ratio of Mezzion Pharma Co.Ltd from 2012 to 2025. This chart shows how Mezzion Pharma Co.Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2012 to 2025. As of June 2026, the ratio stands at -69.3%, reflecting working capital of ₩-27.06 Billion against net assets of ₩39.04 Billion KRW. Explore 140410 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Mezzion Pharma Co.Ltd Working Capital to Net Assets Ratio by Year (2012–2025)
Mezzion Pharma Co.Ltd working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Mezzion Pharma Co.Ltd from 2012 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Mezzion Pharma Co.Ltd.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -197.7% | ₩-33.99 Billion | ₩17.19 Billion | ₩45.59 Billion | ₩79.57 Billion | ▼ -230.8 pp |
| 2024 | 33.1% | ₩15.26 Billion | ₩46.06 Billion | ₩41.93 Billion | ₩26.67 Billion | ▼ -39.5 pp |
| 2023 | 72.6% | ₩44.63 Billion | ₩61.44 Billion | ₩74.24 Billion | ₩29.62 Billion | ▼ -2.9 pp |
| 2022 | 75.5% | ₩19.82 Billion | ₩26.24 Billion | ₩45.90 Billion | ₩26.08 Billion | ▲ +2.8 pp |
| 2021 | 72.7% | ₩45.68 Billion | ₩62.79 Billion | ₩64.17 Billion | ₩18.50 Billion | ▼ -6.7 pp |
| 2020 | 79.5% | ₩45.15 Billion | ₩56.81 Billion | ₩60.67 Billion | ₩15.51 Billion | ▼ -10.0 pp |
| 2019 | 89.5% | ₩38.34 Billion | ₩42.83 Billion | ₩51.85 Billion | ₩13.51 Billion | ▼ -1.7 pp |
| 2018 | 91.2% | ₩52.28 Billion | ₩57.32 Billion | ₩70.02 Billion | ₩17.74 Billion | ▼ -2.8 pp |
| 2017 | 94.1% | ₩50.01 Billion | ₩53.17 Billion | ₩70.50 Billion | ₩20.49 Billion | ▼ -53.1 pp |
| 2016 | 147.2% | ₩77.71 Billion | ₩52.81 Billion | ₩94.19 Billion | ₩16.48 Billion | ▲ +13.5 pp |
| 2015 | 133.7% | ₩83.61 Billion | ₩62.54 Billion | ₩97.33 Billion | ₩13.72 Billion | ▲ +44.3 pp |
| 2012 | 89.4% | ₩56.63 Billion | ₩63.34 Billion | ₩59.57 Billion | ₩2.94 Billion | — |